Evidence map›Paper›PMID 38590737›Full record

ArticleOpen forum infectious diseases2024

Hepatitis Delta Virus Reporting Requirements in the United States and Territories: A Systematic Review.

Milaveh Assadi-Rad, Brenda E Acosta, Matthew C Hesterman, Braden S Fallon, Rachel L Hill, Ethan W Farnsworth, Bree Barbeau, Dede Vilven, Keisa M Lynch, Melodie L Weller

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Milaveh Assadi-RadSchool of Dentistry, University of Utah, Salt Lake City, Utah, USA.
Brenda E AcostaSchool of Dentistry, University of Utah, Salt Lake City, Utah, USA.
Matthew C HestermanSchool of Dentistry, University of Utah, Salt Lake City, Utah, USA.
Braden S FallonSchool of Dentistry, University of Utah, Salt Lake City, Utah, USA.
Rachel L HillSchool of Dentistry, University of Utah, Salt Lake City, Utah, USA.
Ethan W FarnsworthUtah Department of Health and Human Services, Salt Lake City, Utah, USA.
Bree BarbeauUtah Department of Health and Human Services, Salt Lake City, Utah, USA.
Dede VilvenSalt Lake County Health Department, Salt Lake City, Utah, USA.
Keisa M LynchDepartment of Gastroenterology and Hepatology, School of Medicine, University of Utah, Salt Lake City, Utah, USA.
Melodie L WellerSchool of Dentistry, University of Utah, Salt Lake City, Utah, USA.ORCID https://orcid.org/0000-0002-6646-1403

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis D virus (HDV) is a rare coinfection with hepatitis B virus. Currently, HDV is not a nationally notifiable disease in the United States. Only 55% of states and territories require HDV reporting, and most lack defined case definitions. Standardization of reporting requirements is crucial for monitoring HDV epidemiology.

Indexed as

HDVhepatitis Delta virushepatitis D virushepDkolmioviridae

Identifiers

PMID38590737
PMCPMC11000145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.